Literature DB >> 22656415

Association between metabolic syndrome and male overactive bladder in a Japanese population based on three different sets of criteria for metabolic syndrome and the Overactive Bladder Symptom Score.

Kenji Ohgaki1, Kazutaka Horiuchi, Yukihiro Kondo.   

Abstract

OBJECTIVE: To investigate whether metabolic syndrome is a risk factor for overactive bladder (OAB) defined by the Overactive Bladder Symptom Score (OABSS).
METHODS: A digital rectal examination of the prostate and an OABSS questionnaire were conducted in 1031 men who visited our hospital for metabolic screening from April 2009 to March 2010. The OABSS includes scores for daytime frequency, nighttime frequency, urgency, and urgency incontinence. Relationships of OAB (defined as OABSS ≥3 with an urgency score ≥2) with metabolic syndrome diagnosed by Japan Society for the Study of Obesity (JASSO), National Cholesterol Education Program-Adult Treatment Panel III (NCEP-ATP III), and International Diabetes Federation (IDF) criteria were examined. The severity of OAB symptoms was compared among younger, middle-aged, and elderly men (<50, 50-64, and ≥65 years old, respectively) with and without metabolic syndrome.
RESULTS: Diagnoses of metabolic syndrome were made in 16.4%, 16.9%, and 12.0% of the men using JASSO, NCEP-ATP III, and IDF criteria, respectively. Regardless of the presence of metabolic syndrome, aging was significantly associated with increased rates of moderate or severe OABSS findings and OAB defined by the OABSS. In middle-aged men, metabolic syndrome had a significant negative association with OAB rate. In elderly men, metabolic syndrome had a significant negative association with the total OABSS.
CONCLUSION: A relationship between age and OAB was observed, but metabolic syndrome did not show a clear association with OAB. Our results suggest that OAB is associated with aging regardless of the presence of metabolic syndrome.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22656415     DOI: 10.1016/j.urology.2012.03.006

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  10 in total

1.  Relationship between neck circumference and overactive bladder in women with metabolic syndrome: a preliminary study.

Authors:  Yigit Akin; Hakan Gulmez; Murat Savas; Serdar Aykan; Ozde Onder; Selcuk Yucel
Journal:  Wien Klin Wochenschr       Date:  2015-04-09       Impact factor: 1.704

Review 2.  Overactive bladder in elderly men: epidemiology, evaluation, clinical effects, and management.

Authors:  Tomas L Griebling
Journal:  Curr Urol Rep       Date:  2013-10       Impact factor: 3.092

3.  Risk factors and factors affecting the severity of overactive bladder symptoms in Korean women who use public health centers.

Authors:  Jungsoo Chae; Eun-Hee Yoo; Yeonseong Jeong; Seungyeon Pyeon; Donguk Kim
Journal:  Obstet Gynecol Sci       Date:  2018-05-08

4.  Increased serum C-reactive protein level is associated with increased storage lower urinary tract symptoms in men with benign prostatic hyperplasia.

Authors:  Shun-Fa Hung; Shiu-Dong Chung; Hann-Chorng Kuo
Journal:  PLoS One       Date:  2014-01-15       Impact factor: 3.240

Review 5.  Evidence for bladder urothelial pathophysiology in functional bladder disorders.

Authors:  Susan K Keay; Lori A Birder; Toby C Chai
Journal:  Biomed Res Int       Date:  2014-05-08       Impact factor: 3.411

6.  Correlation between overactive bladder symptom score and neuropsychological parameters in Alzheimer's disease patients with lower urinary tract symptom.

Authors:  Ha Bum Jung; Don Kyoung Choi; Seong Ho Lee; Sung Tae Cho; Hae Ri Na; Moon Ho Park
Journal:  Int Braz J Urol       Date:  2017 Mar-Apr       Impact factor: 1.541

7.  Excessive accumulation of visceral fat is associated with lower urinary symptoms including overactive bladder in female patients.

Authors:  Asato Otsubo; Yasuyoshi Miyata; Tomohiro Matsuo; Yuta Mukae; Kensuke Mitsunari; Kojiro Ohba; Hideki Sakai
Journal:  Int J Urol       Date:  2020-12-29       Impact factor: 3.369

8.  Protocol for development and validation of a prediction model for 5-year risk of incident overactive bladder in the general population: the Nagahama study.

Authors:  Satoshi Funada; Yan Luo; Takashi Yoshioka; Kazuya Setoh; Yasuharu Tabara; Hiromitsu Negoro; Shusuke Akamatsu; Koji Yoshimura; Fumihiko Matsuda; Toshi A Furukawa; Orestis Efthimiou; Osamu Ogawa
Journal:  BMC Urol       Date:  2021-05-13       Impact factor: 2.264

9.  Metabolic syndrome is associated with prostate enlargement: a systematic review, meta-analysis, and meta-regression on patients with lower urinary tract symptom factors.

Authors:  Asma Omran; Bianca M Leca; Eduard Oštarijaš; Natasha Graham; Ana Sofia Da Silva; Zoulikha M Zaïr; Alexander D Miras; Carel W le Roux; Royce P Vincent; Linda Cardozo; Georgios K Dimitriadis
Journal:  Ther Adv Endocrinol Metab       Date:  2021-12-08       Impact factor: 3.565

10.  Clinical Efficacy of Solifenacin in the Management of Diabetes Mellitus-Associated Versus Idiopathic Overactive Bladder Symptoms: A Multicenter Prospective Study.

Authors:  Hoon Choi; Jae Hyun Bae; Cheol Young Oh; Seong Jin Jeong; Woo Jin Ko; Jong Bo Choi; Ju Tae Seo; Dong Hwan Lee; Joon Chul Kim; Kwang Woo Lee; Young Ho Kim
Journal:  Int Neurourol J       Date:  2018-03-31       Impact factor: 2.835

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.